Additional Relevant Details An ongoing Phase 1 trial that includes a dose escalation phase and three expansion cohorts, including a homogenous population of 125 AML patients who relapsed after bone marrow transplantation, are in second or later relapse, refractory to second line induction or reinduction treatment. The study’s primary objectives are to confirm the safety and clinical activity of AG-120